ContractCenturium Capital Partners 2018, L.P. • November 25th, 2020 • Biological products, (no disgnostic substances)
Specific parts of this Exhibit have been redacted because confidential treatment for those parts has been requested. The redacted materials have been separately provided to the Securities and Exchange Commission, and the redacted parts have been marked at the appropriate places with three asterisks [***]
